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The pathophysiology of both viral and bacterial meningitis is still poorly
understood ; brain damage after infection of meninges and of the central ner-
vous system may be mediated directly by the infectious agent or may be the
effect of the inflammatory host response to infection. There is accumulating evi-
dence that macrophage-derived cachectin is implicated in many tissue injuries.
Cachectin is identical with TNF-a, which was originally discovered in the sera of
endotoxin-treated mice and rabbits after infection with Bacillus Calmette-Guerin
by its destructive effect on tumor cells in vitro. When passively immunized with
antisera against cachectin/TNF-a, mice were found to be protected against the
lethal effect of endotoxin. Furthermore, injection of cachectin/TNF-a into rats
causes hemorrhagic necrosis, which is indistinguishable from the pathologic
effects seen after endotoxin administration (see reference 1 for review) .
In the present study, we assessed the presence of TNF-a in cerebrospinal fluid
(CSF) during bacterial or viral meningitis in both mice and humans and found
considerable levels of TNF-a early after initiation of bacterial but not at any time
during virally induced meningitis.
Materials and Methods
Mice.
￿
6-8-wk-old inbred (C57B1/6 (H-2b) and outbred ICR and ICR nu/nu mice of
either sex were obtained from the breeding colony of the Institut fur Zuchthygiene, Tier-
spital, Zurich, Switzerland.
Viruses. Lymphocytic choriomeningitis virus (LVMV) Armstrong was originally
obtained from Dr. M. Buchmeier, Scripps Clinic and Research Foundation, La Jolla, CA.
Virus dilutions were made in MEM containing 2% of heat-inactivated FCS.
Culturing and Enumeration of Bacteria.
￿
A seed of Listeria monocytogenes was originally
received from Dr. R. V. Blanden, Australian National University, Canberra (2), and was
maintained in a virulent state by passage in mice. A frozen stock was used to prepare a
fresh 12-16-h culture in Trypticase soy broth (BBL Microbiology Systems, Cockeysville,
MD) for each experiment and the infectious dose was assessed retrospectively by plating
each inoculum. Viable bacterial counts were determined in individual spleens and livers
as described by Mackaness (3).
Infection and Harvesting of Blood and Cerebrospinal Fluid.
￿
Animals were inoculated
intracerebrally (i.c.) or subcutaneously (s.c.) with either ^-600 CFU of Listeria or 100
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plaque-forming units (PFU) of LCMV Armstrong. On days indicated, mice were ether
anaesthesized and bled out; the serum was obtained after centrifugation of blood in
Microtainers" (Becton Dickinson & Co., Rutherford, NY). CSF was collected as described
by Carp et al. (4); CSF samples of 3-10 animals were pooled. After centrifugation, cells
in the pellets were counted and supernatants were used for TNF titration.
TNF Assay.
￿
TNF-a was quantitated in a bioassay using the TNF-sensitive L-M cells
(5) . Data are given as percent survival rate or as units of TNF-a, 1 U/ml being defined
as the concentration that results in lysis of 50% of the L-M cells. The detection limit of
TNF-a in CSF was ^" 0.3 U/ml. For characterization of the cytotoxic activity in CSF, the
samples were incubated either with an excess of rabbit anti-recombinant murine or anti-
recombinant human TNF-a antiserum (generated by Genentech Inc., South San Fran-
cisco, CA and kindly provided by Dr. G. R. Adolf, Ernst-Boehringer-Institut fur Arz-
neimittelforschung, Vienna, Austria) or with control rabbit serum. After 2 h at 37°C,
residual cytotoxicity was determined by adding the test samples to L-M cells.
Human CSFand Serum Samples.
￿
CSF samples were tested for TNF-a activity from (a)
seven patients (four male, three female, 14-65 yr old) with meningococcal (three
patients) or pneumococcal (four patients) meningitis; (b) seven patients with aseptic men-
ingitis caused by echo virus (two patients), coxsackie virus (three patients), or mumps
virus (two patients); (c) seven patients with confirmed diagnosis of multiple sclerosis; and
(d) five patients with other neurological diseases (OND) such as motoneuron disease (one
patient), peripheral neuropathy (one patient), and chronic cephalea (three patients). The
samples were collected from patients treated in the Department of Infectious Diseases,
University Hospital, Linkbping and the Department of Neurology, Karolinska Institute,
University Hospital, Huddinge, Sweden.
Results and Discussion
Mice i.c . infected with Listeria exhibited the first signs of disease 8-12 h after
inoculation of the bacterium and died within the first 4 d after infection irre-
spective of whether the injected dose was 6 (mean day of death 3.8 ± 0.4) or
6,000 CFU (mean day of death 3 .2 ± 0.4). The clinical course of disease was
independent of the presence of mature T cells since no differences with respect
to susceptibility and time point of onset of disease could be observed between
inbred C57B1/6 (H-2b) mice and outbred ICR +/+ and nu/nu mice (H-29)
(Table I). Infection of C57B1/6 mice injected i.c. with 600 CFU resulted in -
15 times higher Listeria titers in their spleen after 24 h when compared with
animals infected s.c. with the same Listeria dose. The difference in bacterial
titers in the spleens of the same strain of mice infected i .c. vs. s.c. was -4 logs
(i.e., 6.3 logs for i.c . injection vs. 2.2 logs for s.c. inoculation) 48 h after infec-
tion; titers were only slightly higher after 72 h (Table I). The number of cells
found in the CSF was drastically augmented ^, 250 times 48 h after i.c. infection
when compared with the s.c. inoculated or control mice. As early as 3 h after
i.c. infection, the number of cells in the CSF started to be increased. Histolog-
ical analysis of the brains 48 h after inoculation of Listeria revealed severe
choriomeningitis.
As described in many studies (6, 7), ICR mice i.c. inoculated with LCMV
showed onset of disease 5-6 d after infection and died 6-8 h later. For C57B1/
6 mice, first signs of the fatal neurological disease could be observed i2-24 h
later. ICR nu/nu mice infected i.c. with LCMV did not develop disease. In his-
tological sections of the brain, first signs of meningitis could be seen in the peri-
vascular space 5 d after infection and on day 6, severe meningitis was observed.a
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TABLE I
Kinetics ofListeria in Liverand Spleen ofDifferent Mouse Strains, Susceptibility to Listerial
Meningitis, and TNF-aProduction in the CSF
Animals were infected i.c. or
S.C . with ^-600 CFUof Listeria in 30 pl. Values shown for Listeria titers are means of
five to six animals; SEM <0.4.
" Groups of five mice.
I TNF-a was measured at 48 h after infection and activities are indicated as U/ml, one unit being defined as the
concentration resulting in 5046 lysis of the L-M cells in the bioassay (see Material and Methods).
TNF titers in the CSF differed vastly between the two meningitis models in
mice; TNF-a could be detected in the CSF of mice (ICR +/+, ICR nu/nu, and
C57B1/6) inoculatd i.c. with Listeria as early as 3 h after infection with a further
increase of TNF-a levels over the next 24-48 h (Fig. IA; Table I) . On the basis
of dilution curves performed with TNF-a and with CSF from ICR mice taken
48 h after infection, the concentration of TNF-a in CSF samples was calculated
to be ^-9,800 U/ml. After i.c. inoculation of Listeria, TNF-a could only be
detected in the CSF but not in the serum of both ICR and C57B1/6 mice (Fig.
IA, Table I) . The s.c. route of infection does not lead to clinical disease, and
the Listeria titers in spleen and liver were much lower than in mice infected i.c.
(see above); TNF-a was also not found in their serum (Fig. 1A) nor in CSF
B
￿
FIGURE 1 .
￿
Presence of TNF-
a in CSF of mice during Lis-
terial, but not LCMV menin-
gitis. (A) At times indicated,
a-o TNF-a was determined in
CSF (-) or serum (---) of
mice inoculated with either
Listeria s.c. (C57B1/6, A) or
i.c. (C57B1/6, A; ICR +/+,
"; ICR nu/nu,*) or with
LCMV i.c. (ICR +/+, a) .
The samples were assayed at
final concentrations of 5% for
CSF and 10% for serum. Data
are expressed as survival rate
(°k of viable cells) of L-Mcells
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response curves were per-
formed with CSF samples
from mice after i.c. infection with either Listeria (ICR+/+, day 2 ") or LCMV (ICR +/+, day 6,
0; C57B1/6, day 7, o). CSF from Listeria-infected ICR +/+ mice was preincubated with a neu-
tralizing polyclonal rabbit anti-murine TNF-a antiserum (final dilution 1 :50) for 2 h (o), The stan-
dard curve (o) was performed with human TNF-a.
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Log,() CFUof listeria per organ TNF-ai
Mouse Route of 24 h 48 h 72 h % Mortality*
strain infection
Liver Spleen Liver Spleen Liver Spleen
(time to death) CSF Serum
U/ml
C57B1/6 S.C . <1 .6 <1.3 2.6 2.2 3.5 3.7 0 0 0
C57B1/6 i.c. 2.8 3.1 5.9 6.3 7.2 6.9 100 (3.3) 4,000 0
ICR +/+ i.c. 2.3 3.4 5.4 6.5 7.5 7.1 100 (3.2) 16,670 0
ICR nu/nu i.c. 2.3 2.9 5.1 6.2 7.2 7.9 100 (3.7) 10,000 01746
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TABLE 11
Differential Cell Counts and Concentration of TNF-aof Mice with Acute
Meningitis
Mice were i.c. infected with either 600 CFU of Listeria or 100 PFU of LCMV. CSF were taken 48
h after inoculation.
` Fixed CSF-derived cells were stained with May-Griinwald/Giemsa; 1,000 cells per sample were
counted. Values indicated represent mean ± SD of two independent experiments.
" See legend Table I.
(Table I). To evaluate whether the cytotoxic activity seen against L-M cells was
mediated by lymphotoxin (TNF-,#) or TNF-a, the CSF samples were pretreated
with anti-TNF-a antiserum before testing. As shown in Figure 1B, the cytotoxic
activity against L-M cells can be neutralized completely with the TNF-a-specific
antiserum but not with control serum. In contrast to what was found in Listeria
infected mice, measurable titers of TNF-a could not be detected in any of the
CSF from mice infected i.c. with LCMV when measured from day 1 to the day
of onset of disease and death (i.e., day 6 for ICR and day 7 for C57B1/6 mice;
Fig. 1, Table 11).
The results obtained in experimental meningitis in mice are paralleled by
detection of TNF-a in patients with bacterial meningitis. Of the seven CSF from
patients with bacterial meningitis, three contained measurable titers of TNF-a
(i.e ., 130 U/ml, 200 U/ml, and 400 U/ml). Based on binding studies using anti-
recombinant human TNF-a antibodies, the activity in CSF could be attributed
to TNF-a. None of the CSF samples from patients with aseptic meningitis
caused by virus (echo, coxsackie, and mumps virus), from patients with multiple
sclerosis, or from patients with other neurologic diseases was positive for TNF.
Of the three patients with TNF in the CSF, two had pneumococcal and one had
meningococcal meningitis. When compared with the four TNF-a negative men-
ingitis patients, the three positive cases do not differ with respect to numbers
of white blood cells in CSF or to CSF/serum albumin ratio; they do differ, how-
ever, with respect to the time point during the course of infection at which the
samples were taken. TNF-a positive CSF were taken from the patients within the
first 24 h of admission to the hospital, the negative CSF samples were obtained
at later time points (i .e., 3-19 d after hospitalization). Recently serum of
patients with diagnosed meningococcal meningitis were examined for TNF-a; of
the 41 samples tested, only four (10%) contained TNF-a at the time point of
hospitalization (8). In our experiments, the intracerebral inoculation of Listeria
in mice was followed by TNF-a production in CSF and growth of Listeria also
outside of the brain, e.g., in the liver and spleen. However, TNF-a could not be
detected in the serum. This observation could either be explained by the differ-
ence of the half life of TNF-a in serum vs. CSF or by faster reticuloendothelial
Time CSF
Mouse
strain Pathogen after Leukocytes Polymorpho- Mononuclear infection per Al nuclear cells" cells` TNF"
d loge, % % U/ml
ICR +/+ Listeria 2 3.6 ± 0.5 92.5 ± 4.6 7.5 ± 4.6 >2,000
ICR +/+ LCMV 6 4.1 ± 0.4 56.1 ± 10.1 43.9 ± 10.1 <0.3
C57111/6 LCMV 7 3.8 ± 0.4 55.1 ± 0.2 44.9 ± 0.2 <0.3LEIST ET AL.
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clearance mechanisms of systemic bacteriaemia when compared with elimination
in the central nervous system (CNS) . Since TNF-a, which can be produced by
activated monocytes/macrophages (1), was detected only in CSF of infected
mice, the factor is likely to be synthesized within the CNS be it either by
recruited blood-derived monocytes or by macrophages of the meninges. In addi-
tion, microglial cells, the macrophage-like cells of the brain, may contribute to
TNF-a production in Listeria infection, a possibility suggested by the finding
that secretion of the factor by activated microglial cells has been demonstrated
in vitro (5). LCMV-induced CNS disease is triggered by cytotoxic T cells (9) with
both T cells and monocytes/macrophages being recruited into the meninges and
CSF (10) . The absence of TNF-a in the CSF of the mice suffering from LCMV
disease suggests that recruited monocytes/macrophages do not play a significant
role in tissue and cell destruction and in development of disease (11, 12), since
despite the presence of both macrophages and activated virus-specific CD8 + T
cells (11), in the LCMV model there is no interaction between T cells and mac-
rophages, apparently resulting in TNF-a production detectable in CSF.
Monocytes/macrophages play a crucial role in host response to bacterial infec-
tion. When certain inducible functions of monocytes/macrophages such as cach-
ectin/TNF-a are expressed inappropriately, the cells may contribute to devel-
opment of tissue injury; e.g., intravenous injection of cachectin/TNF-a into rats
mimics the clinical symptoms and tissue lesions including severe vascular damage
seen after endotoxin administration (1). Secretion of TNF-a into the CSF could
be important in initiating damage of the blood brain barrier and the tissue
injury observed in bacterial meningitis (13). Thus cachectin/TNF-a may exert
direct cytotoxic effects and/or operate by acting on polymorphonuclear cells,
the main inflammatory cells detected in CSF during Listerial meningitis; cach-
ectin/TNF-a has been found to be chemotactic for polymorphonuclear cells and
to cause superoxide anion release by granulocytes (14, 15). Further studies are
needed to assess the effects of cachectin/TNF-a within the CSF and to establish
whether the examination of CSF for cachectin/TNF-a may be helpful in differ-
entiating between bacterial and viral meningitis in human patients with acute
disease.
Summary
To evaluate the potential role of cachectin/TNF-a in the pathogenesis of bac-
terial and viral meningitis, concentrations and kinetics of TNF-a were deter-
mined in cerebrospinal fluid (CSF). After intracerebral, but not systemic, infec-
tion with Listeria monocytogenes in mice, TNF-a was detected as early as 3 h after
infection reaching maximum titers after 24 h. However, TNF-a was not found
in serum during the course of Listeria infection. In contrast to bacterial men-
ingitis, no TNF-a was detected at any time in CSF of mice suffering from severe
lymphocytic choriomeningitis induced by intracerebral infection with lympho-
cytic choriomeningitis virus. This difference is striking since both model infec-
tions led to a massive infiltration of polymorphonuclear and mononuclear leu-
kocytes into the meninges and CSF. The results found for the two model
infections were paralleled by findings in humans; CSF from three out of three1748
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patients with bacterial meningitis examined during the first day of hospitaliza-
tion showed significant levels of TNF-a; none of the CSF obtained later than 3
d after hospitalization was positive. In addition, similarly to what was found in
mice with viral meningitis, zero out of seven patients with viral meningitis had
detectable TNF-a in CSF.
Received for publication 19 November 1987 and in revisedform 23 February 1988.
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